Data availability
All original data can be obtained upon reasonable request directed to the first author.
References
Choi HSJ, Brouwer WP, Zanjir WMR, et al. Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B. Hepatology. 2020;71(2):539–548
Huang SC, Su TH, Tseng TC, et al. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B. Hepatol Int. 2023;17(5):1139–1149
Mao X, Cheung KS, Peng C, et al. Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: a systematic review and meta-analysis. Hepatology. 2023;77(5):1735–1745
van Meer S, van Erpecum KJ, Sprengers D, et al. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands. Eur J Gastroenterol Hepatol. 2016;28(3):352–359
Wong YJ, Nguyen VH, Yang HI, et al. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis. Clin Mol Hepatol. 2023;29(3):705–720
Mak LY, Hui RW, Fung J, et al. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B. J Hepatol. 2020;73(4):800–806
Funding
Robert J. de Knegt consults and received grants from AbbVie. He is on the speakers’ bureau for Echosens. He received grants from Gilead and Janssen. We confirm that the parties mentioned above have been involved in this manuscript or have funded this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have not disclosed any competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ayada, I., Li, J., Brouwer, W.P. et al. Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinoma. Hepatol Int 18, 1053–1055 (2024). https://doi.org/10.1007/s12072-024-10639-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12072-024-10639-9